A correction has been applied to this article in:
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
Ana Jiménez-Ubieto1*†
Alejandro Martín-Muñoz1,2†María Poza1Sara Dorado2,3
Almudena García-Ortiz1Enrique Revilla4Pilar Sarandeses5Yanira Ruiz-Heredia1,2Tycho Baumann1Antonia Rodríguez1María Calbacho1Pilar Martínez Sánchez1José María Sánchez Pina1
Alejandro Martín García-Sancho6Gloria Figaredo1Laura Rufián1,2Margarita Rodríguez1,2Laura Carneros1Carolina Martínez-Laperche7
Mariana Bastos-Oreiro7Chongwu Wang8María-Teresa Cedena1Inmaculada Rapado1Paula de Toledo3
Miguel Gallardo1Antonio Valeri1Rosa Ayala1Joaquín Martínez-López1Santiago Barrio1,2*- 1Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain
- 2Altum sequencing Co., Madrid, Spain
- 3Computational Science Department, Carlos III University, Madrid, Spain
- 4Departamento de Anatomía Patológica, Hospital Universitario 12 de Octubre, Madrid, Spain
- 5Departamento de Medicina Nuclear, Hospital Universitario 12 de Octubre, Madrid, Spain
- 6Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
- 7Hospital General Universitario Gregorio Marañón, Madrid, Spain
- 8Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China
By Jiménez-Ubieto A, Martín-Muñoz A, Poza M, Dorado S, García-Ortiz A, Revilla E, Sarandeses P, Ruiz-Heredia Y, Baumann T, Rodríguez A, Calbacho M, Sánchez PM, Pina JMS, García-Sancho AM, Figaredo G, Rufián L, Rodríguez M, Carneros L, Martínez-Laperche C, Bastos-Oreiro M, Wang C, Cedena M-T, Rapado I, de Toledo P, Gallardo M, Valeri A, Ayala R, Martínez-López J and Barrio S (2023). Front. Immunol. 14:1188818. doi: 10.3389/fimmu.2023.1188818
In the published article, there was an error in the author list, and author Miguel Gallardo was erroneously excluded. The corrected author list appears below:
Ana Jiménez-Ubieto1*†, Alejandro Martı´n-Muñoz1,2†,María Poza1, Sara Dorado2,3, Almudena García-Ortiz1, Enrique Revilla4, Pilar Sarandeses5, Yanira Ruiz-Heredia1,2, Tycho Baumann1, Antonia Rodríguez1, María Calbacho1, Pilar Martínez Sánchez1, José María Sánchez Pina1, Alejandro Martín García-Sancho6, Gloria Figaredo1, Laura Rufián1,2, Margarita Rodríguez1,2, Laura Carneros1, Carolina Martínez-Laperche7, Mariana Bastos-Oreiro7, Chongwu Wang8, María-Teresa Cedena1, Inmaculada Rapado1, Paula de Toledo3, Miguel Gallardo1, Antonio Valeri1, Rosa Ayala1, Joaquín Martínez-López1 and Santiago Barrio1,2.
The updated author contribution section appears below:
AJ-U, AM-M, MP, and SB designed the research. LR, AG-O, ER, PS and MR performed the experiments. AM-M, YR-H, SD, CW, and SB defined the bioinformatic pipeline and performed sequencing data analysis. AJ-U, MP, ER, TB, AR, MC, GF, M-TC, RA and JM-L provided patient samples and clinical data. Author MG contributed to the conception, design and manuscript revisions. All authors analyzed and interpreted the data. AJ-U, AM-M, MP, and SB wrote the manuscript which was approved by all authors.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: follicular lymphoma, ctDNA (circulating tumor DNA), NGS (Next-Generation Sequencing), minimal residual disease, monitoring, PET/CT 18F-FDG, CAR T-cell therapy
Citation: Jiménez-Ubieto A, Martín-Muñoz A, Poza M, Dorado S, García-Ortiz A, Revilla E, Sarandeses P, Ruiz-Heredia Y, Baumann T, Rodríguez A, Calbacho M, Sánchez PM, Pina JMS, García-Sancho AM, Figaredo G, Rufián L, Rodríguez M, Carneros L, Martínez-Laperche C, Bastos-Oreiro M, Wang C, Cedena M-T, Rapado I, de Toledo P, Gallardo M, Valeri A, Ayala R, Martínez-López J and Barrio S (2023) Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients. Front. Immunol. 14:1243241. doi: 10.3389/fimmu.2023.1243241
Received: 20 June 2023; Accepted: 08 August 2023;
Published: 16 August 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Jiménez-Ubieto, Martín-Muñoz, Poza, Dorado, García-Ortiz, Revilla, Sarandeses, Ruiz-Heredia, Baumann, Rodríguez, Calbacho, Sánchez, Pina, García-Sancho, Figaredo, Rufián, Rodríguez, Carneros, Martínez-Laperche, Bastos-Oreiro, Wang, Cedena, Rapado, de Toledo, Gallardo, Valeri, Ayala, Martínez-López and Barrio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ana Jiménez-Ubieto, YW5pdGlqdUBob3RtYWlsLmNvbQ==; Santiago Barrio, c2FudGlhZ29fYmFycmlvQGFsdHVtc2VxdWVuY2luZy5jb20=
†These authors have contributed equally to this work